Two New Vaccines Join the Fight to Eradicate Polio
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
University of California San Francisco
Give to UCSF
Breast Density and BMI Both Play a Role in Breast Cancer Risk
Laws in many states require notifying women if they have dense breasts, a risk factor for breast cancer. But density shouldn’t be the only factor in determining whether supplemental screening is
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
Personalizing Prostate Cancer Screening May Improve Accuracy of Detection
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
Can Hydrocortisone Improve Patient Outcomes from Septic Shock?
In sepsis cases, hydrocortisone is found to decrease the need for blood pressure-raising drugs and improves survival when used in combination with other corticosteroids.
Scientists Discover a Deadly Brain Cancer’s Hidden Weakness
UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.
Transgender Women Benefit from Prostate Cancer Screenings
Transgender women keep their prostates even after gender-affirming surgery, and the estimated risk of prostate cancer is at about 14 cases per 10,000 people.
UCSF Improves Care Options for Metastatic Gastrointestinal Cancer
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.
UCSF Improves Care Options for Metastatic Gastrointestinal Cancer
UCSF's Division of Surgical Oncology is currently the only center in Northern California offering surgical insertion of hepatic artery infusion (HAI) for patients.
Drug Resistance, Targeted Cell Therapies Among Cancer Conference Talks
Leading cancer researchers from UCSF will present at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, held April 14-19, 2023, in Orlando.
Does Taxing Sugary Drinks Lead to Improved Health During Pregnancy?
Pregnant women have a lower risk of gestational diabetes and unhealthy weight gain in cities that tax sugary drinks, according to a first-of-its-kind study of more than 5 million women by UCSF.
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
